Uehara, Shotaro
Iida, Yuichi
Ida-Tanaka, Miyuki
Goto, Motohito
Kawai, Kenji
Yamamoto, Masafumi
Higuchi, Yuichiro
Ito, Satoshi
Takahashi, Riichi
Kamimura, Hidetaka
Ito, Mamoru
Yamazaki, Hiroshi
Oshimura, Mitsuo
Kazuki, Yasuhiro
Suemizu, Hiroshi
Funding for this research was provided by:
Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (20K06463)
The Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP) from Japan Science and Technology (AS2414006Q)
The Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from AMED (21am0101124, 21am0101121)
Grant-in-aid for Life Science Joint Research in City of KAWASAKI (rinkoku2013-1)
Article History
Received: 19 March 2022
Accepted: 26 August 2022
First Online: 1 September 2022
Competing interests
: M.O. is a CEO, employee, and shareholder of Trans Chromosomics, Inc. The other authors report no conflict of interest.